Mesoblast (MESO) Interest Expenses (2015 - 2025)
Mesoblast's (MESO) quarterly Interest Expenses came in at $10.8 million in Q2 2025, up 4.56% year-on-year from $10.3 million in Q2 2024, and up 4.56% quarter-over-quarter from $10.3 million in Q2 2024.
Mesoblast (MESO) Interest Expenses (2015 - 2025) Analysis & Trends
Mesoblast has disclosed Interest Expenses across 11 years of filings, most recently posting $10.8 million for Q2 2025.
- Interest Expenses for Q2 2025 came in at $10.8 million, up 4.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.1 million (changed 0.5% YoY), and the FY2025 annual result was $23.0 million, changed 0.18% from the prior year.
- Interest Expenses came in at $10.8 million for Q2 2025 at Mesoblast, up from $10.3 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $12.9 million in Q2 2022 to a low of -$4.9 million in Q1 2023.
- The 5-year median for Interest Expenses is $9.0 million (2021), against an average of $4.4 million.
- Peak annual rise in Interest Expenses reached 2323.82% in 2021, while the deepest fall reached 282.58% in 2021.
- Mesoblast's Interest Expenses stood at -$4.1 million in 2021, then jumped by 362.98% to $10.7 million in 2022, then changed by 0.0% to $10.7 million in 2023, then declined by 3.43% to $10.3 million in 2024, then gained by 4.56% to $10.8 million in 2025.
- The last three Interest Expenses figures came in at $10.8 million (Q2 2025), $10.3 million (Q2 2024), and $10.7 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 10.79 Mn |
| Jun 30, 2025 | 10.79 Mn |
| Jun 30, 2024 | 10.32 Mn |
| Jun 30, 2024 | 10.32 Mn |
| Jun 30, 2023 | 10.69 Mn |
| Jun 30, 2023 | 10.69 Mn |
| Mar 31, 2023 | -4.90 Mn |
| Mar 31, 2023 | -4.90 Mn |
| Dec 31, 2022 | 10.69 Mn |
| Dec 31, 2022 | 10.69 Mn |
| Sep 30, 2022 | -4.55 Mn |
| Sep 30, 2022 | -4.55 Mn |
| Jun 30, 2022 | 12.94 Mn |
| Jun 30, 2022 | 12.94 Mn |
| Mar 31, 2022 | -4.30 Mn |
| Mar 31, 2022 | -4.30 Mn |
| Dec 31, 2021 | -4.06 Mn |
| Dec 31, 2021 | -4.06 Mn |
| Sep 30, 2021 | -4.14 Mn |
| Sep 30, 2021 | -4.14 Mn |